Article
Molecular diagnostic testing for congenital disorders of glycosylation (CDG): detection rate for single gene testing and next generation sequencing panel testing.
Molecular genetics and metabolism - 1 Jan 2000
Jones Melanie A, Rhodenizer Devin, da Silva Cristina, Huff Israel J, Keong Lisa, Bean Lora J H, Coffee Bradford, Collins Christin, Tanner Alice K, He Miao, Hegde Madhuri R
Abstract excerpt
Congenital disorders of glycosylation (CDG) are comprised of over 60 disorders with the majority of defects residing within the N-glycosylation pathway. Approximately 20% of patients do not survive beyond five years of age due to widespread organ dysfunction. A diagnosis of CDG is based on abnormal glycosylation of transferrin but this method cannot identify the specific gene defect. For many individuals...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
